Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Newton

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of the Neurological Sciences|June 30, 2020
Excellent reliability of the ALSFRS-R administered via videoconferencing: A study of people with motor neuron disease in ScotlandJudith Newton, Kiran Jayaprakash, Stella A Glasmacher, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 29, 2025
Impact of apathy over the course of disease in amyotrophic lateral sclerosisRatko Radakovic, Debbie Gray, Ana Paula Trucco, et al.
Journal of Neurology|September 5, 2020
The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in ScotlandStella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Journal of Neurology|October 20, 2020
Correction to: The immediate impact of the COVID‑19 pandemic on motor neuron disease services and mortality in ScotlandStella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 8, 2017
Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)Christopher Crockford, Judith Newton, Katie Lonergan, et al.
Journal of Neurology|June 9, 2024
Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in ScotlandDanielle J Leighton, Morad Ansari, Judith Newton, et al.
Neurology|September 14, 2018
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALSChristopher Crockford, Judith Newton, Katie Lonergan, et al.
Science Advances|April 21, 2023
Cell-autonomous immune dysfunction driven by disrupted autophagy in <i>C9orf72</i>-ALS iPSC-derived microglia contributes to neurodegenerationPoulomi Banerjee, Arpan R Mehta, Raja S Nirujogi, et al.
BMJ Open|July 7, 2022
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron diseaseCharis Wong, Rachel S Dakin, Jill Williamson, et al.
Brain Communications|June 30, 2026
Blood-based biomarker discovery in motor neuron disease using nucleic acid-linked immuno-sandwich assayHatice Bozkurt, Katy R Reid, Judith Newton, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of the Neurological Sciences|June 30, 2020
Excellent reliability of the ALSFRS-R administered via videoconferencing: A study of people with motor neuron disease in ScotlandJudith Newton, Kiran Jayaprakash, Stella A Glasmacher, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 29, 2025
Impact of apathy over the course of disease in amyotrophic lateral sclerosisRatko Radakovic, Debbie Gray, Ana Paula Trucco, et al.
Journal of Neurology|September 5, 2020
The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in ScotlandStella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Journal of Neurology|October 20, 2020
Correction to: The immediate impact of the COVID‑19 pandemic on motor neuron disease services and mortality in ScotlandStella A Glasmacher, Juan Larraz, Arpan R Mehta, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 8, 2017
Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)Christopher Crockford, Judith Newton, Katie Lonergan, et al.
Journal of Neurology|June 9, 2024
Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in ScotlandDanielle J Leighton, Morad Ansari, Judith Newton, et al.
Neurology|September 14, 2018
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALSChristopher Crockford, Judith Newton, Katie Lonergan, et al.
Science Advances|April 21, 2023
Cell-autonomous immune dysfunction driven by disrupted autophagy in <i>C9orf72</i>-ALS iPSC-derived microglia contributes to neurodegenerationPoulomi Banerjee, Arpan R Mehta, Raja S Nirujogi, et al.
BMJ Open|July 7, 2022
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron diseaseCharis Wong, Rachel S Dakin, Jill Williamson, et al.
Brain Communications|June 30, 2026
Blood-based biomarker discovery in motor neuron disease using nucleic acid-linked immuno-sandwich assayHatice Bozkurt, Katy R Reid, Judith Newton, et al.
Pageof 5